1-10 of 10
Authors: Gilles Pialoux
Journal Article
Incidence and factors associated with PrEP discontinuation in France Get access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 7, July 2024, Pages 1555–1563, https://doi.org/10.1093/jac/dkae133
Published: 17 May 2024
Journal Article
HIV-1-RNA and total HIV-1-DNA loads in the genital compartment in men receiving dolutegravir- versus darunavir-based combined ART (cART) regimens during primary HIV infection Free
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 3, March 2022, Pages 735–739, https://doi.org/10.1093/jac/dkab427
Published: 23 November 2021
Journal Article
Tenofovir disoproxil fumarate and emtricitabine maintenance strategy in virologically controlled adults with low HIV-1 DNA: 48 week results from a randomized, open-label, non-inferiority trial Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 6, June 2021, Pages 1564–1572, https://doi.org/10.1093/jac/dkab038
Published: 16 March 2021
Journal Article
Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM Free
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 7, July 2020, Pages 1961–1968, https://doi.org/10.1093/jac/dkaa091
Published: 19 April 2020
Journal Article
Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial) Free
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 8, August 2016, Pages 2252–2261, https://doi.org/10.1093/jac/dkw103
Published: 10 April 2016
Journal Article
Initiation of rilpivirine, tenofovir and emtricitabine (RPV/TDF/FTC) regimen in 363 patients with virological vigilance assessment in ‘real life’ Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 12, December 2014, Pages 3335–3339, https://doi.org/10.1093/jac/dku294
Published: 11 August 2014
Journal Article
Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 12, December 2014, Pages 3360–3367, https://doi.org/10.1093/jac/dku295
Published: 04 August 2014
Journal Article
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 6, June 2014, Pages 1648–1652, https://doi.org/10.1093/jac/dkt536
Published: 16 February 2014
Journal Article
Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance Get access
Journal of Antimicrobial Chemotherapy, Volume 64, Issue 2, August 2009, Pages 398–410, https://doi.org/10.1093/jac/dkp198
Published: 10 June 2009
Journal Article
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study Get access
Journal of Antimicrobial Chemotherapy, Volume 64, Issue 1, July 2009, Pages 118–125, https://doi.org/10.1093/jac/dkp146
Published: 06 May 2009
